All In Biotech

Drug Trial Radar · NCT01818336

Evaluation of Skin Testing Reagents for Penicillin Allergy

Confirmatory Study to Examine Negative Predictive Value (NPV) and Safety of Skin Testing With PRE-PEN, a Minor Determinant MIxture (MDM) of Penicillin Antigens, and Amoxicillin Reagent Against an Oral Challenge With Amoxicillin

Last checked: Nov 20, 2026Latest source record: Jan 4, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

481

Actual

Start

Dec 2012

Primary completion

Jun 2013

Study completion Jun 2013

Sponsor

Lead sponsor
AllerQuest LLCIndustry
Sponsor type
Industry
First posted
Mar 26, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A self- or parent-reported history of penicillin allergy excludes approximately 10% of the US population from receiving penicillin (Kerr 1994, Kagy, Blaiss 1998, Solensky et al. 2000, Neugut et al. 2001). Yet approximately 80% of patients labeled as allergic to the penicillins can safely take these antibiotics without fear of a life-threatening reaction (Gadde et al. 1993, Macy et al. 1997). The outcomes of this erroneous classification of patients include unnecessary denial of an effective and well-tolerated class of antibiotics, which are often the treatment of choice. The primary aim of skin testing with the Penicillin Skin Test Kit is to identify subjects at very low risk of developing acute IgE-dependent reactions when given a penicillin or cross-reacting drug. The negative predictive value (NPV) of skin testing is assessed by oral challenge with a penicillin.

Conditions

  • History of IgE Dependent Reaction to a Penicillin Product

Interventions

  • Penicillin skin test kitDrug

    Allergy skin testing is done by puncture and intradermal. If all tests negative, subjects receive an oral amoxicillin challenge.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Negative Predictive ValueTime frame: 72 hours

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Alabama Allergy & Asthma Center

    Homewood, Alabama

  • Allergy Associates of Tucson

    Tucson, Arizona

  • Allergy & Asthma Clinical Research

    Walnut Creek, California

  • Fairfield County Allergy, Asthma & Immunology Assoc., Inc.

    Norwalk, Connecticut

  • Ct. Asthma & Allergy Center LLC

    West Hartford, Connecticut

  • Windom Allergy

    Sarasota, Florida

  • Atlanta Allergy and Asthma Clinic

    Atlanta, Georgia

  • Mayo Clinic

    Rochester, Minnesota

  • Washington University Medical School

    St Louis, Missouri

  • Midwest Allergy & Asthma Clinic PC

    Omaha, Nebraska

  • Corvallis Clinic

    Corvallis, Oregon

  • Allergy & Asthma Care

    Germantown, Tennessee

  • Northwest Asthma & Allergy Center

    Redmond, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.